// M&A

All signals tagged with this topic

Apr 15

Uber commits $10B to robotaxi buildout over next few years

Uber is shifting from pure platform operator to hardware investor and buyer, committing $7.5B to vehicle purchases and $2.5B to equity stakes in robotaxi manufacturers. The move signals that autonomous fleets will replace human drivers within its core business. This is a structural change in how ride-hailing companies compete. Rather than waiting for robotaxi technology to mature at arm's length, Uber is directly funding and owning pieces of the supply chain, locking in pricing and technical alignment while signaling to regulators and the market that driverless is operational, not speculative. The equity stakes matter most: Uber becomes a stakeholder in manufacturers' success, tying the company's valuation directly to whether autonomous vehicles work at scale.

theme-commerce Fintech M&A

Apr 6

CoinShares Goes Public on Nasdaq After $1.2B SPAC Deal

Source: Theblock

CoinShares, a crypto asset manager, completed a $1.2B SPAC merger with Vine Hill and began trading on Nasdaq under ticker CSHR on April 1. This marks the company's entry into US public markets and signals institutional legitimacy for cryptocurrency asset management.

theme-connected Infrastructure M&A

Apr 3

SpaceX Files for Record $75 Billion IPO as Starlink Monetizes

Source: Morning Brew

SpaceX filed paperwork for an IPO seeking to raise $75 billion at a $1.75 trillion valuation, potentially setting a record for the largest public listing. The filing indicates the company plans to go public as soon as June, with the offering driven by Starlink's ability to generate revenue and monetize its satellite internet service.

theme-ai AI & ML M&A

Apr 2

Anthropic Acquires Biotech Startup Coefficient for $400M

Source: Newcomer

Anthropic is betting that Claude’s reasoning capabilities can compress the drug discovery timeline by automating molecular design and protein folding—the labor-intensive work that makes biotech expensive and slow. The $400M acquisition shows AI labs are moving beyond chatbots into verticals with measurable ROI, where a 10% improvement in hit rates or candidate screening affects pharma economics. Anthropic also gains a team already embedded in wet biology rather than retraining its own people, while Coefficient avoids the difficult path of selling enterprise AI tools as a standalone vendor.